CURR News and Press, Cure Pharmaceutical Holding Corp From 03/23/21

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has secured an extension to its Schedule I U.S. Drug Enforcement Agency (DEA) license that ...

Cure Pharmaceutical Holding Corp. (CURR) has begun an initiative that will examine whether the use of psychedelic compounds on its oral film drug delivery platform CUREfilm can treat mental illnesses.The psychedelics included are psilocybin (found in "magic" mushrooms), LSD, and MDMA (ecstasy...

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched a new initiative for the clinical development of psychedelic compounds such as...

CURE Pharmaceutical (CURR) announces that it has launched two new clinical development programs and added new corresponding products to its pharmaceutical pipeline.The first is an antiviral clinical development program where CURE will look to load a known active pharmaceutical ingredient ((AP...

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs and added new corresponding products to ...

Sleep A.S.A.P. provides proof of concept and monetization for CURE’s patented oral thin-film technology CURE Pharmaceutical Holding Corp . (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery ...

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced this week’s start of its...

Mexico with 121 million citizens will likely legalize cannabis by April of this year opening the door to the largest population for potential customers; This will be a game-changing tipping point for legalization of cannabis around the world and especially throughout Latin America; ...

CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its Board of Directors. After a...

CURE Pharmaceutical ([[CURR]] +5.0%) company Sera Labs unveils ImmunD₃, an oral thin-film that provides a weekly dose of Vitamin D (40,000 IU) as a part of its Nutri-Strips line vitamins and supplements.Nutri-Strips products are designed using the RAD₃ (Rapid Activatio...